Key statistics
As of last trade Faron Pharmaceuticals Oy (4FR:BER) traded at 2.59, -30.10% below its 52-week high of 3.71, set on Dec 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.60 |
---|---|
High | 2.60 |
Low | 2.57 |
Bid | 2.43 |
Offer | 2.76 |
Previous close | 2.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 104.62m |
Free float | 71.27m |
P/E (TTM) | -- |
Market cap | 225.99m GBP |
EPS (TTM) | -0.3191 GBP |
Data delayed at least 15 minutes, as of Sep 20 2024 11:12 BST.
More ▼
Announcements
- Grant of options
- Faron 2024 Half-Year Financial Results
- FDA Grants Fast Track Designation for Bexmarilimab
- Notice of Half-Year Financial Results
- Traumakine Research Collaboration and DoD Grant
- Appointment of Chief Financial Officer
- Grant of options
- Faron Appoints Dr. Petri Bono as new CMO
- Faron Announces Positive FDA Feedback
- Update on settlement
More ▼